Sept. 15, 2014—This symposium in San Francisco, Oct. 17-18, will examine a a big data approach to biomarker discovery and clinical assay diagnostic assay development in oncology that Munich-based Definiens is calling tissue phenomics. Speakers include Definiens co-founder and Nobel Laureate Gerd Binnig, PhD. Learn more.